- Home
- ITRG vs BLUE Comparison
ITRG vs BLUE Comparison
Compare ITRG & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- BLUE
- Stock Information
- Founded
- ITRG 1997
- BLUE 1992
- Country
- ITRG Canada
- BLUE United States
- Employees
- ITRG N/A
- BLUE N/A
- Industry
- ITRG Precious Metals
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITRG Basic Materials
- BLUE Health Care
- Exchange
- ITRG Nasdaq
- BLUE Nasdaq
- Market Cap
- ITRG 92.0M
- BLUE 78.7M
- IPO Year
- ITRG N/A
- BLUE 2013
- Fundamental
- Price
- ITRG $0.91
- BLUE $0.38
- Analyst Decision
- ITRG Strong Buy
- BLUE Hold
- Analyst Count
- ITRG 1
- BLUE 11
- Target Price
- ITRG $3.75
- BLUE $4.63
- AVG Volume (30 Days)
- ITRG 369.7K
- BLUE 5.0M
- Earning Date
- ITRG 11-13-2024
- BLUE 11-14-2024
- Dividend Yield
- ITRG N/A
- BLUE N/A
- EPS Growth
- ITRG N/A
- BLUE N/A
- EPS
- ITRG N/A
- BLUE N/A
- Revenue
- ITRG N/A
- BLUE $53,120,000.00
- Revenue This Year
- ITRG N/A
- BLUE $199.14
- Revenue Next Year
- ITRG $360.52
- BLUE $186.62
- P/E Ratio
- ITRG N/A
- BLUE N/A
- Revenue Growth
- ITRG N/A
- BLUE 144.50
- 52 Week Low
- ITRG $0.64
- BLUE $0.34
- 52 Week High
- ITRG $1.28
- BLUE $5.53
- Technical
- Relative Strength Index (RSI)
- ITRG 32.16
- BLUE 30.06
- Support Level
- ITRG $0.91
- BLUE $0.34
- Resistance Level
- ITRG $1.10
- BLUE $0.53
- Average True Range (ATR)
- ITRG 0.06
- BLUE 0.03
- MACD
- ITRG -0.03
- BLUE -0.01
- Stochastic Oscillator
- ITRG 3.00
- BLUE 21.35
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.